Change in metabolic tumor activity on F-18-FDG PET after a single dose of cetuximab to predict for treatment benefit, PFS, and OS in patients with advanced colorectal cancer.

Research output: Contribution to journalArticleAcademicpeer-review

Original languageEnglish
JournalJournal of clinical oncology
Volume35
DOIs
Publication statusPublished - 20 May 2017

Cite this